Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

A coalition establishes a secure, direct link between a physical tablet and a digital backend for supply chain integrity.

Study Demonstrates Digitalization of Tablets

Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade CBD and THC product to treat MS spasticity using Catalent’s orally disintegrating tablet technology.


Catalent, Ethicann Partner on Fast-Dissolve Cannabinoid Treatment for MS Spasticity

Gary Dailey is vice-president, Global Marketing, Electronic Materials, at Avantor.

Claudia BerrÃ³n is senior vice-president, Strategy and Commercial Operations, Biopharma Production at Avantor.

Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.

Applying Lessons Learned from the Semiconductor Industry

Nicole Fontourcy is head of Visualization Technology, Pall Corporation

Visualization using virtual and mixed reality can aid with biopharma manufacturing facility design and training.

Visualization Enhances Facility Design

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The key is to ensure that excipients only interact with APIs via desired mechanisms.

Managing Excipient Interactions

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Spray drying is a versatile and rapid technique that can provide companies with a suitable and scalable option to improve the solubility and bioavailability of drug products.


Tackling Solubility in Drug Development

As regulatory bodies extend the oversight of E&L testing, companies working with drug products need to make provisions on how to best comply with the evolving expectations.


Meeting E&L Expectations

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Trends affecting primary pharmaceutical packaging include the shift to more complex drug-device combination products.

Primary Packaging for Combination Products

Gayatri C.Patel, M.Pharm, PhD, is associate professor in the Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy at the Charotar University of Science and Technology, Changa Campus, Changa- 388 421, Anand, Gujarat, India, gayatripatel.ph@charusat.ac.in, +91 2697 265162.

Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis. 


Optimizing Compression Coating for Pulsatile Release Tablets

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

PATH’s Microarray Patch Center of Excellence aims to accelerate transdermal patch technology for public health needs.